Interestingly, AML cell lines in which mutations of SRSF2, SF3B1 or U2AF1 have been introduced are more sensitive to indisulam-induced cell death than their non-mutated counterparts [152]. This evidence concerns the gene SRSF2 and acute myeloid leukemia.